Multidisciplinary Association for Psychedelic Studies (MAPS).

A research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.

Proud to Support

  • Clinical trials for MDMA-assisted therapy as a treatment for PTSD   READ MORE »

Proud to Highlight

  • FDA designated MDMA-assisted therapy as a Breakthrough Therapy
  • Latest clinical trial results show that 67% of participants no longer have a PTSD diagnosis
Psychedelic research has been thought of as ‘fringe’ for a long time. But there’s nothing ‘fringe’ about PTSD. There are millions of people with PTSD in the U.S. alone, and that includes veterans like me, first-responders like those on the front lines of the COVID-19 pandemic, and survivors of sexual assault and domestic abuse. All of them deserve better, significantly more effective treatment options than we give them today. That’s what this research is about.
- Bob Parsons